MIRA
INFORM REPORT
|
Report Date : |
04.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
WIN MEDICARE PRIVATE LIMITED |
|
|
|
|
Registered Office : |
1400, Modi Tower, 98 Nehru Place, New Delhi – 110 019 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
28.04.1981 |
|
|
|
|
Com. Reg. No.: |
55-11647 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U51397DL1981PTC011647 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
DELW01075E |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACWO631J |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturer of Pharma, Cosmetics – Colour Cosmetic and Personal
Care Products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 3300000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Management remained non co-operative and irresponsible during our investigations.
(We tried to reach various staff such as Mr. Bansal, Mr. Amit Gupta, Mr. Arun
Jain, Ms. Shobha, Mr. Manisha, Mr. Das Ghosh etc.) Subject is a well – established company having satisfactory track. Financial position is satisfactory. Payments are usually correct and as per commitments. General financial position is satisfactory. The company can be considered normal for business dealings
at usual trade terms and conditions. |
LOCATIONS
|
Registered Office : |
1400, Modi Tower, 98 Nehru Place, New Delhi – 110 019, India |
|
Tel. No.: |
91-11-66504555 / 66504560 |
|
Fax No.: |
91-11-26451659 / 26449030 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory 1 : |
Meerut - Muzzafarnagar Road, Modipuram, District Meerut - 250 011, Uttar Pradesh Tel. No. 91-121-2570214/2570215/16/2571114 Fax. No. 91-121-2570983 Unit No. 8-10, 1st Floor, Shree Madhu Industrial Estate, Pandu Rang Budhkar Marg, Worli-400013, Mumbai, Maharashtra Tel. No. : 91-22-24948635/24968606/24948870 Fax. No. : 91-22-24950560
Tel. No. : 91-33-22260165/22261920 Fax. No. : 91-33-22457364
Tel. No. : 91-44-28271505 Fax. No. : 91-44-28227351 International Marketing 1108, Modi Tower, 98 Nehru Place, New Delhi – 110 019, India Tel. No.: 91-11-51617708 Fax No.: 91-11-26451659
Tel. No. : 91-11-26286581 - 85 Fax. No. : 91-11-26480115 Hrd/ Accounts/ Purchase
Tel. No. : 91-11-26829145/26847458/90 Fax. No. : 91-11-26915805 |
DIRECTORS
|
Name : |
Mr. Umesh Kumar Modi |
|
Designation : |
Chairman |
|
Address : |
36, Amrita Shergil Marg, New Delhi, India |
|
Date of Birth/Age : |
05.03.1951 |
|
Date of Appointment : |
21.03.1990 |
|
|
|
|
Name : |
Ms. Kum Kum Modi |
|
Designation : |
Managing Director |
|
Address : |
36, Amrita Shergil Marg, New Delhi, India |
|
Date of Birth/Age : |
19.01.1951 |
|
Date of Appointment : |
01.04.1995 |
|
|
|
|
Name : |
Dr. Bal Kishan Agarwal |
|
Designation : |
Director |
|
Address : |
108, Sameer Vihar, Modinagar, Uttar Pradesh, India |
|
Date of Birth/Age : |
21.01.1944 |
|
Date of Appointment : |
08.05.1981 |
|
|
|
|
Name : |
Mr. Anupam Bansal |
|
Designation : |
Director |
|
Address : |
R-2/35, Rajnagar, Ghaziabad, Uttar Pradesh, India |
|
Date of Birth/Age : |
29.09.1953 |
|
Date of Appointment : |
06.03.1990 |
|
|
|
|
Name : |
Ms. Himani Agarwal Modi |
|
Designation : |
Director |
|
Address : |
36, Amrita Shergil Marg, New Delhi, India |
|
Date of Birth/Age : |
27.05.1974 |
|
Date of Appointment : |
27.05.1992 |
|
|
|
|
Name : |
Mr. Abhishekh Modi |
|
Designation : |
Director |
|
Address : |
36, Amrita Shergil Marg, New Delhi, India |
|
Date of Birth/Age : |
22.12.1975 |
|
Date of Appointment : |
11.03.1994 |
|
|
|
|
Name : |
Mr. Rajiv Sawhney |
|
Designation : |
Director |
|
Address : |
52 – A, Friends Colony, New Delhi, India |
|
Date of Birth/Age : |
02.10.1947 |
|
Date of Appointment : |
28.03.2000 |
KEY EXECUTIVES
|
Name : |
Mr. Sudeep Shahi |
|
Designation : |
Manager - Business Development
|
|
|
|
|
Name : |
Mr. Manish Narang |
|
Designation : |
Company Sectary |
|
Address : |
Flat No.: 209, Pocket GH – 1, Archana Apartment, Paschim Vihar, New Delhi – 110 063, India |
|
Date of Birth/Age : |
31.08.1970 |
|
Date of Appointment : |
01.05.1999 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
(As on 30.06.2006)
|
Names of Shareholders |
No. of Shares |
|
M/s. Modi-Mundi Pharma Limited |
321080 |
|
M/s. Own Investments (India) Limited |
24000 |
|
M/s. Your Investment (India) Private Limited |
24000 |
|
Mehta B Himmat Lal (JT) |
1000 |
|
Jugal Kishore Parikh |
500 |
|
Hukimichand Dayama |
500 |
|
Rajesh Sachdev |
500 |
|
Pankaj R Jogatar |
500 |
|
Kamal Kishore |
500 |
|
Shashi Luthra |
10 |
|
Bindu Kumar Luthra |
10 |
|
Others |
2 |
|
|
|
|
Total |
372602 |
Equity shares Breakup (percentage of total equity)
(As on 30.06.2007)
|
Category |
Percentage |
|
Bodies Corporate |
99.00 |
|
Other top fifty (50) shareholders |
1.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Pharma, Cosmetics – Colour Cosmetic and
Personal Care Products. |
|
|
|
|
Products : |
· Povidone Iodine · Nalidixic Acid ·
Diclofenac Sodium |
|
|
|
|
Brand Names : |
Winthrop", "Betadine",
"Diclonol", "Corion", "Pregnorm",
"Gonablock", etc. |
|
|
|
|
Exports : |
|
|
Countries : |
South Asian, African and Middle East, Russia, South
Africa, Vietnam, Bangladesh, Maldives, Sri Lanka and Nepal. |
|
|
|
|
Imports : |
|
|
Countries : |
USA, Germany, Switzerland |
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash and Credit (30 / 60 days) terms |
|
|
|
|
Purchasing : |
L/C or Credit (30 / 60 days) terms |
GENERAL
INFORMATION
|
Customers : |
· Ambica Parenterals Containers · Bela Insutruments · Mahim Polyprints Private Limited · Modi Motots Private Limited · Pest Control India Private Limited · S S Bedi & Sons · Shyam Industries · Sun Control Systems ·
Transgeniks & Vineet Packaging Industries |
|
|
|
|
Bankers : |
· State Bank of India, Modinagar, Uttar Pradesh · Standard Chartered Grindlays Bank Limited, Connaught Circus, New Delhi - 110 001 · Hongkong Bank, New Delhi - 110 011 ·
Allabhabad Bank, Nehru Place, New Delhi - 110 019 ·
HDFC Bank Limited – 1st Floor, Kailash
Building, 26, K. G. Marg, New Delhi, India |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
K. K. Jain & Company Chartered Accountants |
|
Address : |
711, Roots Tower, District Centre, Laxmi Nagar, New Delhi – 110 092,
India |
|
|
|
|
Associates/Subsidiaries : |
Ř
Win
Health Care Private Limited Ř
Modi Sugar Mills Modinagar-201204, Uttar Pradesh Tel. No. : 91-1232-242540/242936 Fax. No.: 91-1232-242532 E Mail : modi sug @ del3.vnsl.net.in Ř
Modi Revlon Limited 1400, Modi Tower, 98, Nehru Place, New Delhi-110 019 Tel. No. : 91-11-26421382/26464082/26464288 Fax. No. : 91-11-26464212/26464082/26452905 6a, Lovely Home Church Lane, Santa Cruz, East Kalina, Mumbai-400 029 Tel. No. : 91-22-26180898 Fax. No. : 91-22-26183489
Tel. No. : 91-33-2296997
Tel. No. : 91-44-28271505 Fax. No. : 91-44-28227351
Tel. No. : 91-80-2270054 Ř
Bihar Sponge Iron Limited 1400, Modi Tower, 98, Nehru Place, New Delhi-110 019 Tel. No. : 91-11-26468748/ 26444638/26442358 Fax. No. : 91-11-26451659
|
|
|
|
|
Group Companies: |
Modi Sugar Mills The foundation stone of the Modi Empire was laid in 1932, when Rai
Bahadur Gujar Mal Modi cast the foundation of the Sugar Plant. From a humble
beginning, this flagship company has now developed into a major agro-based
industry. Modi Sugar Mills, located in the heart of sugarcane
producing belt of Western Uttar Pradesh, is completely modernised and
automated. It produces 60,000 tonnes of high quality white crystal sugar per
annum and is now renowned as one of the most efficient sugar plants in
Northern India. With its manufacturing unit located at Modinagar (erstwhile
Begumbad) and the quality product marketed throughout Northern India, Modi
Sugar Mills is manned by qualified technical personnel. The company’s
commitment towards quality and perfection has helped its smooth sail through
the years and also contributed to the diversification of the Group. Modi Distillery Modi Distillery is one of India’s modern alcohol processing units
established in 1959, the distillery has kept pace with advances in technology
& is a leading manufacturer of a range of high quality alcohols. The
plant is integrated with Modi Sugar Mills, processes alcohol from molasses, realizing maximum
process efficiencies. The distillery’s major product line is industrial
alcohol – a key intermediate input into many growth industries such as
pharmaceuticals, paint & rubber. The unit
converts rectified spirit, at 15 kilolitres per day, into various
concentrations of country liquor. The company also caters to the
domestic market for potable alcohol through select mid-segment alcohol brands
and now venturing into branded IMFL liquor for the retail market. The Modi Distillery is ever alive to
the all-important issue of environment pollution. It has an elaborate
of effluent treatment that insures effective recycling of waste &
neutralization of toxic discharges. Bihar
Sponge Iron Limited BSIL is the first commercial sponge
iron plant in India and is also recognised as the most efficient coal-based plant
in India. The plant is located at Umesh Nagar, Chandil, in district
Singhbhum, which is 30 kms from Jamshedpur. Chandil is a known backward
tribal area in the state of Bihar, where their unit produces Sponge Iron from
indigenous iron ore and non-coking coal available abundantly in the vicinity. The implementation of this massive project started in June
1986 and was completed in record time. The plant started commercial
production in July 1989. Sponge Iron is used as a raw material for making
steel in electric arc furnaces and induction furnaces, substituting and
supplementing indigenous and imported scrap. Win -
Medicare Limited What began
as a vision of healthcare business in early 1980s, Win-Medicare today is
amongst the fastest growing pharmaceutical companies in India and is
considered the undisputed leader in select segment. In a country with a
highly fragmented pharma market, Win-Medicare enjoys a respectable share.
Sourcing technologies, pharmaceutical and healthcare products as well as the
latest in Research and Development from USA, Germany and Switzerland,
Win-Medicare has grown from strength to strength while pursuing its mission
of fulfilling the healthcare needs of the country. Win-Medicare began its business with a number of
pioneering concepts and products from Sterling Drug Inc., USA and concertedly
worked towards making them established contemporary medical practice. In the mid-Eighties, Win-Medicare took a quantum leap and
tied up with Mundipharma Group of Companies, a pharmaceutical giant from
Switzerland. Mundipharma AG, Switzerland and its R&D and manufacturing
affiliates, Napp Pharmaceutical Group, UK and the Purdue Frederick Co., USA
are renowned for their novel formulation expertise, state-of-the-art
production and Quality Assurance facilities. The biggest gain from this
venture is the topical microbicide Betadine. In 75 countries, Betadine is
trusted for its uncompromising antiseptic efficacy. Amongst the recent growth and expansion bids, Win-Medicare
has established licencing arrangement with Merz & Co. GmbH, Germany for
marketing their hepatotherapeutic and other pharma-ceutical products and
IBSA, Switzerland for bolstering it’s gynaecological portfolio. The company
is well represented through an efficient Marketing and Distribution network
in the Domestic, South Asian, African and Middle East markets. Currently the
company offers options for infection control, pain relief, management of
infertility and many other specialised areas. Modi
Mundipharma Limited Encouraged by the success of
Win-Medicare, another landmark joint-venture was formed to serve the health
needs of the country. Christened Modi-Mundipharma Limited, the tie-up with
the Mundipharma Group of Switzerland has further strengthened the Group’s
position in the pharmaceutical segment. A rapidly growing pharma company, Modi-Mundipharma draws
its primary strength from sound Research and Development as well as existing
and effective formulations of the Mundipharma Group companies world-wide.
Medical fraternity, across the length and breadth of India, perceives
Modi-Mundipharma to be a pharma company that offers long acting formulations
in specialised therapeutic segments. Modi-Mundipharma has reached this
position with consistent exposure of the benefits of revolutionary Continus
technology at large and subsequent discussions of the brand benefits derived
from controlled drug delivery. The focus of Modi-Mundipharma is to offer state-of-the-art
and latest high-tech pharmaceutical solutions through introduction of
differentiated products in the field of Asthma, Pain and Heart diseases. The
company is effectively represented in the Domestic and South Asian markets. Modi
Revlon Limited It
started with one single product ... a nail enamel ... Modi-Revlon is the formidable
alliance between the Modi Group and the world famous Revlon of USA.
Modi-Revlon has entered the Indian market and has redefined the concept of beauty
care in India. It brings to the Indian women an exciting range of
international cosmetics, toiletries and fragrances - all adapted to suit the
local conditions and preferences. Modi-Revlon draws on the expertise of
Revlon’s premier Research Centre in Edison, New Jersey (USA), to harmonise
its international product offerings with the needs and preferences of the
Indian women. The company ‘thinks Global, but
acts Local’. The manufacturing standards of Modi-Revlon are as exacting as
elsewhere in the world. The toughest QC standards in line with the global
norms are followed. The products’ advertising features international
celebrities and super models. Modi-Revlon’s product portfolio currently
consists of Lipsticks, Nail Enamels, Eye and Face Make-up, Flex Shampoos,
Flex Conditioners, Charlie Cologne, Body Sprays, Talc and Fire and Ice
cologne. Sbec
Systems (India) Limited To provide high technology to the
sugar industry in India, SBEC Systems (India) Limited was incorporated in
1987. The company was set up in technical and financial collaboration with
SBEC Systems (UK). The major products of the company include High Torque Low
Speed Hydraulic Transmission Systems, Bagasse Drying-cum-Air Pollution
Control Systems, Microprocessor-based Control Systems, Continuous Vacuum Pans
and Long Tube Evaporators. Additionally,
SBEC provides Engineering & Consultancy Services for the purpose of
designing modern sugar plants, expansion/modernisation of existing sugar
plants and integration of co-generation facilities. These products are
environmentally safe and have proven track records. The benefits derived from
their implementation in a sugar plant include : 1. Savings in energy 2.
Improvement in sugar recovery from cane as well as improvement in the quality
of sugar, and 3. Reduction in air pollution/emission. SBEC (India) is receiving, on an ongoing basis, designs of
proprietary and patent processes and systems from SBEC Systems (UK). These
systems are being sold to the sugar industry as components of bagasse-based
co-generation systems and the sugar manufac-turing process. The identification and development of new technologies
suited to the sugar industry worldwide, is a process that SBEC Systems (UK)
maintains as its prime activity to remain in the forefront of technological
advancements and thus enhance the contents of its basket of technologies and
patents. Sbec
Sugar Limited Building upon past experiences and blending
the most modern technology in sugar industry led to the formation of SBEC
Sugar Limited Promoted by
Modi Group and SBEC Systems Limited, UK, (led by Mr. NorlandSuzor, an
internationally acclaimed sugar technologist). SBEC Sugar has access to the
cutting edge technology in sugar manufacture - the promoter company is a
global player in project design, engineering and consultancy. SBEC Sugar has commenced production of high quality white
crystal sugar at its plant located in the heart of the sugar-cane belt of
Western UP. The unit has an installed capacity of 60,000 tonnes of sugar per
annum which will increase to 100,000 tonnes per annum in the second year of
operation. The plant proposes to meet its entire power needs through captive
generation. It incorporates a technologically intensive effluent treatment
and disposal system, conforming to the most stringent environmental norms. In a trailblazing effort, the company is marketing its
high quality ‘branded’ sugar in an array of innovative packaging solutions.
This is supported by an extensive national multi-media advertising campaign
aimed at creating rapid product awareness and a strong brand identity in an
effort to offer value added products to a very discerning and demanding
consumers of today. SI-AL
SBEC Bioenergy Limited The company SI-AL-SBEC Bioenergy
Limited has been established to implement the co-generation project for
generation and supply of power to the SBEC Sugar Limited for in-house
consumption and supply of excess power to the state electricity grid. The
company has already entered into a long term conversion agreement with SBEC
Sugar for providing power and steam to the sugar unit against the supply of
bagasse and water from the sugar plant. The project is being implemented in financial
collaboration with Air Liquid, France and SIDEC, France. Air Liquid is a
world leader in Industrial Gases and SIDEC is a leading player in power
generation which finances, builds and operates power plants in order to meet
the needs of industrial clients. SIDEC currently owns 30 power plants in
France. Power and steam are the two critical inputs vital to any process
industry. For industries that have a continuous requirement of both steam and
power, co-generation is the most economical option. This is where
technological expertise matters. In most sugar mills, the associated
co-generation is seen as a by-product whose benefits and efficiency are seen
as inconsequential. The technology for bagasse-based co-generation for the
export of power is wellknown and commercially practised in several countries,
notably the United States, Mauritius and Dominican Republic. The gestation
period for such projects is less than that of conventional thermal or hydro
power projects. Morgardshammer
India Limited Morgardshammar India Limited, set
up in 1983, is a joint venture between the Modi Group and Morgardshammar AB
of Sweden. Morgardshammar AB is a world renowned company in the field
of design, manufacture and supply of Wire Rod and Bar Mills including their
Guide Equipment. Being pioneers in the field of Guides, they cater to over
70% of the world market for Guides. The joint venture company is engaged in design,
manufacture and supply of Guide Equipment including Roller Guides, Friction
Guides, Escapement Repeaters and Loopers, etc. The company is well
established and catering to 70% of Guides market in India. Technicast
Engineers Limited Technicast
Engineers Limited is a joint venture between Modi Group and Technical
Investment Limited of UK. The company is engaged in the production of
Continuously Cast Grey Iron Bars in several sizes and sections. This is the first
foundry of its kind in India in which the unique production process results
in metallurgically superior Cast Iron Bars as compared to conventional and casting
products. The computer-controlled process results in a consistent,
homogeneous product, free from typical foundry defects such as blow holes,
pin holes, shrinkages and porosity The product has wide ranging applications in Hydraulic
Equipment, Textile Machinery, Glass Bottle Industry, Machine Tools and
General Engineering Industry. Modi
Motors Private Limited Modi Motors
Private Limited was incorporated in 1985 as the authorised exclusive dealer
of Volvo cars in India. It is dedicated exclusively to aid the import of
Volvo in India or anywhere in the world as a part of the Volvo Tourist &
Diplomat Sales Network, Sweden Volvo develops products and services which take its
commitment closer to people. Being one of the most renowned and respected
automobile brands in the world, Volvo understands its responsibility and
offers people more value and excellence. Partnership with customers is the
motto of Modi Motors and to execute this, Modi Motors offers a plethora of
services. After Sales Service is its forte and the company takes
pride in undertaking the servicing of the world’s safest car, Volvo, along
with other imported cars at its exclusive service station located at Gurgaon.
The service station, equipped with trained personnel and genuine spare parts,
is dedicated to provide services of international standards. Modi Motors
brings to India the concept of ‘Total Car Solutions’. Modi Motors, though a small organisation today, aims to
spread its wings throughout the country in future. Modi –Senator (India) Private Ltd Modi-Senator (India) Private Limited is a 50:50 joint venture between
Modi Group and Merz & Krell GmbH of Germany. Senator’, a subsidiary of Merz & Krell, is one of the leading
manufacturers of writing instruments in the world & No. 1 manufacturer of
Ball Pens in Germany. ‘Senator’ is a household name in Germany
with over 50% market share and is making its name in the overseas market with
a presence in over 90 countries. Senator Writing Instruments has been
associated with some of the most successful product launches worldwide.
The
range of Modi Senator writing Instruments includes a wide range of ball pen,
roller balls, fountain pens, mechanical pencils, highlighters and
markers. These writing Instruments are being imported from Germany ensuring
world class quality, performance and styling for brand launches, consumer
promotions, incentives, PR activity, corporate gifting etc. Modi senator has set a state-of-the
art printing facility in New Delhi for customized imprinting on the writing
instruments with logo, brands, advertising messages etc. the Italian
printing machines not only reproduce logos of the highest quality but ensure
that the printing lasts much longer than any normal printing giving the
advertising message a longer life. Modiline
Travel Service Private Limited Modiline Travel Service Private
Limited is a compact and determined travel company with a mission to provide
its customers a high standard of travel related services. At Modiline, the
attempt is to be flexible and innovative so that customer needs are catered
to in every circumstance and to the minutest possible detail. Modiline believes that personalised attention, derived
from an indepth understanding of customer needs, is the basis of a
quality-led service platform. Hence, Modiline remains committed to giving its
customers that all important organisational resource - time. The Company is
equipped to understand customers’ distinct requirements and deliver
value-based service. Recognising the need for a comprehensive service umbrella,
Modiline offers its clients an integrated package of services, which include
: ·
Passport and
visa facilitation ·
Airport
Transfers ·
Cargo
services including custom clearance and trans-shipment. ·
Domestic
and International ticketing ·
Travel
planning and itinerary management including domestic and international hotel
bookingsForeign exchange services, with doorstep delivery
of exchange Modi Leasing and Capital
Services Limited With economic liberalisation sweeping across the country, the financial
services industry in India is poised for tremendous growth. Having foreseen
this scenario, Modi Group decided to widen the ambit of its activities. It
diversified into Asset Financing and Capital Market Operations through Modi
Leasing & Capital Services (MLCS) in mid-1992. In its first two years of operations, MLCS has primarily
concentrated on Corporate Advisory Services as there emerged an imperative
need to carry out its diversified operational activities including future
expansion plans by way of fund-based activities. More recently, MLCS has
ventured into Merchant and Investment Banking, Capital Market Intermediation,
International Advisory Services and Public Deposit Mobilisation. The endeavour of MLCS lies in providing expertise in the
field of finance and merchant banking and covers the following range of
activities : Corporate
Advisory Services : ·
Financial
Structuring ·
Arrangement
Long Term ·
Arranging
Working Capital Borrowings ·
Bills
Discounting Facilities ·
Temporary/short
term Loans and Deposits ·
Pricing of
Premium Equity and Debentures Merchant Banking :
Future Plans : a) Foreign Exchange Advisory
Services :
b) Project Advisory Services
Assistance in
Letter of Intent, Foreign Collaboration approval, etc. |
|
|
|
|
Holding Company : |
Modi-Mundi Pharma Limited 613, Modi Tower, 98, Nehru
Place, New Delhi-110 019 Tel. No. :
91-11-26451648/26286581-85 Fax. No. : 91-11-26451659 Hrd/Accounts/Purchase
B-12, Okhla Industrial Area,
Phase-II, New Delhi-110 020 Tel. No. :
91-11-26924836/26847458/90 Fax. No. : 91-11-26915805 Plants
Meerut - Muzzafarnagar Road,
Modipuram-250 110, U.P. Tel.
No. : 91-121-2570214/2570215 Fax.
No. : 91-121-2570983 Unit
No. 8-10, 1st Floor, Shree Madhu Industrial
Estate, Pandu Rang Budhkar Marg, Worli, Mumbai -400013, Maharashtra Tel.
No. : 91-22-24948635/24968606/24948870 Fax.
No. : 91-22-24950560 121,
Park Centre Ist Floor, 24, Park Street, Kolkata - 700 001, West Bengal Tel.
No. : 91-33-2296997 3, Palat
Shankaran Road, Mahalinga Puram,
Chennai-600 034, Tamilnadu Tel. No. : 91-44-28271505 Fax. No. : 91-44-28227351 |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
5000000 |
Equity shares |
Rs. 10/- each |
Rs. 50.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
372602 |
Equity shares |
Rs. 10/- each |
Rs. 3.726 millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.12.2006 |
31.12.2005 |
31.12.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
3.726 |
3.726 |
3.726 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
659.477 |
517.835 |
428.750 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
663.203 |
521.561 |
432.476 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
8.063 |
8.115 |
9.884 |
|
|
2] Unsecured Loans |
72.103 |
149.979 |
130.666 |
|
|
TOTAL BORROWING |
80.166 |
158.094 |
140.550 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
|
TOTAL |
743.369 |
679.655 |
573.026 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
112.828 |
111.699 |
94.256 |
|
|
Capital work-in-progress |
0.000 |
1.825 |
0.759 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.150 |
0.100 |
0.500 |
|
|
DEFERREX TAX ASSETS |
20.632 |
12.802 |
3.899 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
273.945
|
219.538 |
179.207 |
|
|
Sundry Debtors |
257.695
|
330.009 |
271.618 |
|
|
Cash & Bank Balances |
113.980
|
62.843 |
123.901 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
644.624
|
519.838 |
305.937 |
|
Total
Current Assets |
1290.244
|
1132.228 |
880.663 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
384.756
|
379.557 |
311.957 |
|
|
Provisions |
295.729
|
199.442 |
95.094 |
|
Total
Current Liabilities |
680.485
|
578.999 |
407.051 |
|
|
Net Current Assets |
609.759
|
553.229 |
473.612 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
743.369 |
679.655 |
573.026 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.12.2006 |
31.12.2005 |
31.12.2004 |
|
|
Sales Turnover |
2431.428 |
2222.995 |
1984.884 |
|
|
Other Income |
0.000 |
0.000 |
0.000 |
|
|
Total Income |
2431.428 |
2222.995 |
1984.884 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
249.475 |
196.477 |
164.224 |
|
|
Provision for Taxation |
107.834 |
107.392 |
32.269 |
|
|
Profit/(Loss) After Tax |
141.641 |
89.085 |
131.955 |
|
|
|
|
|
|
|
|
Earnings in Foreign Currency : |
|
|
|
|
|
|
Export Earnings |
62.628 |
61.380 |
56.313 |
|
|
|
|
|
|
|
Imports : |
|
|
|
|
|
|
Finished Goods |
51.240 |
53.754 |
|
|
|
Raw Materials |
49.117 |
52.355 |
|
|
|
Stores & Spares |
0.126 |
0.079 |
|
|
|
Capital Goods |
0.000 |
1.624 |
|
|
|
Others |
0.166 |
0.321 |
|
|
Total Imports |
100.649 |
108.133 |
98.056 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Financial Charges |
23.467 |
24.211 |
0.000 |
|
|
Depreciation & Amortization |
14.620 |
12.558 |
0.000 |
|
|
Other Expenditure |
2143.866 |
1989.749 |
0.000 |
|
Total Expenditure |
2181.953 |
2026.518 |
1780.587 |
|
KEY RATIOS
|
PARTICULARS |
|
31.12.2006 |
31.12.2005 |
31.12.2004 |
|
PAT / Total Income |
(%) |
5.83
|
4.01 |
6.65 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
10.26
|
8.84 |
8.38 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
17.78
|
15.79 |
16.76 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.38
|
0.38 |
0.38 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.15
|
1.41 |
1.27 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.90
|
1.96 |
2.16 |
LOCAL AGENCY
FURTHER INFORMATION
Form
No. 8
|
Name of the company |
WIN MEDICARE PRIVATE LIMITED |
|
Presented By |
Win Medicare Private Limited and HDFC Bank Limited |
|
1) Date and description of instrument creating the change |
Letter of
Hypothecation of Stocks dated 12.12.2005 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Facilities or
accommodation upto a maximum principal amount of Rs.9.500 millions by way of
Letter of Credit and/or Bank Guarantee. |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
First charge by
way of hypothecation of Company’s Stocks upto the value of Rs.30.000 millions
in trade both present and future consisting of Finished goods now or at any
time and from time to time hereafter stored or brought into or upon or in
course of transit to our central warehouse at Modinagar, gate no.3, Modi
Steel, Modinagar (Uttar Pradesh), whatsoever and whosoever in our possession
or occupation or at any other premises or place. |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Tenor: LC – Maximum
90 days of LC oe expiry of cycle whichever is earlier. BG – Maximum 15
months Margin : 15% cash
margin on LC and BG outstanding |
|
5) Name and Address and description of the person entitled to the charge. |
HDFC Bank Limited – 1st Floor, Kailash Building,
26, K. G. Marg, New Delhi, India |
|
Corporate
identity number of the company |
U51397DL1981PTC011647 |
|
Name of the
company |
WIN MEDICARE PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in India of the company |
1400, Hemkunt Tower, 98 Nehru Place, New Delhi – 110 019 |
|
This form is for |
Modification of
charge |
|
Type of charge |
Hypothecation |
|
Particular of
charge holder |
HDFC Bank Limited HDFC Bank House, Senapati
Bapat Marg, Lower Parel (West), Mumbai – 400 013, Maharashtra, India |
|
Amount secured by
the charge |
Rs.9.500 millions |
|
Description of
the property charged indicating whether it is a charged on |
Stock in trade |
|
Particulars of the
property charged |
First charge by
way of hypothecation of company’s stock upto the value of Rs.50.000 millions
both present and future consisting of finished goods now or at any time
hereafter belonging to the company or at company’s disposal and now or at any
time hereafter stored or to be stored or brought into or upon in course of
transit to company’s central warehouse at Modi Nagar, gate no.3, Modi Steel,
Modi Nagar (Uttar Pradesh) whatsoever in company’s possession or occupation
or at any other premises or place. |
|
Charge
identification number of the charge to be modified |
|
|
Brief description
of the instrument modifying the charge under section 135 |
Letter of
Hypothecation of Stocks dated 18.05.2006 |
|
Date of
instrument modifying the charge |
18.05.2006 |
|
Particulars of
the present modification |
Facilities
increased from Rs.9.500 millions to Rs.20.000 millions by way of letter of
credit and Guarantees. |
Audhorised Distributor:
v
Sterling
Drug Inc, USA
v
Mundipharma
UG., Switzerland
v
Pharmaceutical
Group
v
Purdue
Frederick Company USA
The subject deals in the following
v
Anagesics
& Anti – Inflammatory
v
Diclomol
Tabs Diclofenac Sodium
v
Soludol
Tabs Diclofenac dispersible tabs 50 mg
v
Relisure
Mefenamic Acid
v
Pentazocine
Injection Pentazocine
v
Antibiotics
& Antiulcerants & Antifungals
v
Atecor
– 50 Atenolol Tabs
v
Gonablok
– 50 Danazol Caps 50 mg
v
Antimalarials
v
Vitamins
v
Hepato
Biliary
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market survey
revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.30 |
|
UK Pound |
1 |
Rs.86.13 |
|
Euro |
1 |
Rs.68.72 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
47 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|